[1] This impressive figure represents 70% of the company's overall revenue for the year
SURMOUNT-2 (Obesity with T2D) Perhaps the most anticipated trial in the program, SURPASS-2 was a 40-week, head-to-head study comparing Tirzepatide (5, 10, and 15 mg) to the highest approved dose of the potent selective GLP-1 RA, semaglutide (1 mg), in 1,878 patients with T2D on a background of metformin
SELENE (GHK-Cu | Tesamorelin) A womans longevity and aesthetic peptide blend designed to support skin health, metabolic function, and hormonal balance
In this section, we will discuss symptoms of low potassium (hypokalemia) and high potassium (hyperkalemia) so you know what to look out for
Pre-existing heart conditions, such as coronary artery disease or angina, increase the risk
Studies indicate that resistance training effectively may prevent muscle loss during caloric restriction